Mohamed Derbala

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Mohamed Derbala

Jan 25, 2025, 04:09 | Science

Mohamed Gouda: Selinexor in Combination with Immune Checkpoint Inhibition in Uveal Melanoma

Mohamed Gouda, Clinical Fellow at the University of Texas MD Anderson Cancer Center, shared a…

Nov 12, 2024, 15:08 | Blog

MD Anderson Research Highlights: SITC 2024 Special Edition

Featuring insights into the tumor microenvironment, targets to overcome treatment resistance, and a novel immunotherapy…

Nov 11, 2024, 11:50 | Societies

Highlights from the 39th Society for Immunotherapy of Cancer Annual Meeting

The 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting was held from November 6–10, 2024,…

Oct 3, 2023, 18:09 | Blog

Mohamed Derbala: Excited to share our latest editorial in JAMA Oncology.

Quoting Mohamed Derbala, Research Scientist at the MD Anderson Cancer Center, on X/Twitter: "Excited to…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023